Stepan Co. (SCL) Misses Q2 EPS by 26c
Tweet
Share
E-mailGet Alerts SCL Hot Sheet
Join SI Premium – FREE
Stepan Co. (NYSE: SCL) reported Q2 EPS of $0.41, $0.26 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $556.41 million versus the consensus estimate of $581.3 million.
For earnings history and earnings-related data on Stepan Co. (SCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Milestone Pharmaceuticals Inc. (MIST) Misses Q2 EPS by 2c
- Rapid7 (RPD) PT Raised to $14 at Canaccord
- Zura Bio Ltd. (ZURA) PT Raised to $20 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
